Automatic Classification of Magnetic Resonance Histology of Peripheral Arterial Chronic Total Occlusions Using a Variational Autoencoder: A Feasibility Study.
Judit Csore, Christof Karmonik, Kayla Wilhoit...
https://pubmed.ncbi.nlm.nih.gov/37296778Actively Recruiting
Led by The Methodist Hospital Research Institute · Updated on 2026-03-19
175
Participants Needed
1
Research Sites
47 weeks
Total Duration
T
The Methodist Hospital Research Institute
Lead Sponsor
N
National Heart, Lung, and Blood Institute (NHLBI)
Collaborating Sponsor
Researchers are studying peripheral arterial disease (PAD) to identify which plaque lesions are impenetrable and to find out which devices cause the least injury to the vessel walls. This observational study includes patients undergoing percutaneous vascular intervention (PVI) and patients undergoing lower limb amputation due to PAD. The study aims to improve understanding of plaque types and their impact on treatment success. Participants in the study will undergo MRI scans before their planned PVI to assess the plaque and predict procedural difficulty. For patients undergoing lower limb amputation, the removed limbs will also receive MRI scans to assess plaques. The study compares two devices, plain balloon angioplasty (POBA) and orbital atherectomy, in amputated limbs to evaluate their effects on the vessel wall and device safety. Plaques are categorized into four types based on MRI-histology: concentric calcium, eccentric calcium, fibrous plaque, and soft plaques. During the study, 100 patients will have scans using a 3T MAGNETOM MRI scanner. Doctors performing the PVI will not see the MRI results and will treat patients according to standard care. Researchers will analyze which plaques predict procedural failures and the need for additional devices or approaches. Outcomes will be measured during the procedure and through histological evaluation of amputated limbs. The study lasts until June 2029 and involves detailed imaging and histological assessments to improve PAD management.
CONDITIONS
MRI Guided Management of Occlusive Peripheral Arterial Disease
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants undergo MRI scans using optimized sequences to characterize plaque types and score lesions before any treatment.
1 imaging visit (in-person)
Duration - Intraprocedural
Participants who undergo standard peripheral vascular interventions are observed to assess procedure outcomes without alteration to their treatment.
During the procedure
Total: 1 location
1
Houston Methodist Hospital
Houston, Texas, United States, 77030
Actively Recruiting
T
Trisha Roy, MD, PhD
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Judit Csore, Christof Karmonik, Kayla Wilhoit...
https://pubmed.ncbi.nlm.nih.gov/37296778Giuseppe Barisano, Farshid Sepehrband, Samantha Ma...
https://pubmed.ncbi.nlm.nih.gov/30359093Nicolas W Shammas, W John Shammas, Susan Jones-Miller...
https://pubmed.ncbi.nlm.nih.gov/32419593Kazunori Horie, Akiko Tanaka, Masataka Taguri...
https://pubmed.ncbi.nlm.nih.gov/30203701Soichiro Ebisawa, Shun Kohsaka, Toshiya Muramatsu...
https://pubmed.ncbi.nlm.nih.gov/32915843Thomas Werncke, Kristina Imeen Ringe, Christian von Falck...
https://pubmed.ncbi.nlm.nih.gov/25835948Jahan Mohebali, Virendra I Patel, Javier M Romero...
https://pubmed.ncbi.nlm.nih.gov/26506272Trisha Roy, Garry Liu, Noor Shaikh...
https://pubmed.ncbi.nlm.nih.gov/27659155Max L A Ebert, Vanessa F Schmidt, Lena Pfaff...
https://pubmed.ncbi.nlm.nih.gov/34869956Charlie C-T Hsu, Gigi Nc Kwan, Dalveer Singh...
https://pubmed.ncbi.nlm.nih.gov/30536919